% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • boxcarlong boxcarlong Mar 16, 2012 10:45 AM Flag

    After the offering Cash position

    around $110M

    Not happy about the price of $12

    They gave their investment bankers the deal of the year.

    I will increase my position under $13.75

    IMO, the stock is still worth $25 PPS

    They have all the needed funds to move 427 into P2b trials in multiple oncology indication and 225 into P1/P2 trials without any delay. No more need to rely on GVT grants to slowly move the pipeline forward.

    IMO, management is signaling that 427 is a significant oncology drug and the program is going to expand big time over next 12/18 months.

    Time will tell


    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.75-0.31(-10.13%)Sep 4 4:00 PMEDT